Endocrinology and Metabolism

Review Article

Hypothalamus and Pituitary gland
Current National and International Guidelines for the Management of Male Hypogonadism: Helping Clinicians to Navigate Variation in Diagnostic Criteria and Treatment Recommendations: Ahmed Al-Sharefi, Richard Quinton; Endocrinol Metab. 2020;35(3):526-540. Published online September 22, 2020; DOI: https://doi.org/10.3803/EnM.2020.760

9,460 View
504 Download
10 Web of Science
11 Crossref

Male hypogonadism—rebadged by some as testosterone deficiency syndrome—is a clinical and biochemical diagnosis of increasing worldwide interest. Organic male hypogonadism—usually permanent—is well-established, but aging men may also exhibit lower serum testosterone levels; principally due to burden of extra-gonadal comorbidities such as obesity, diabetes and metabolic syndrome, but with an underlying intact hypothalamo-pituitary-testicular (HPT) axis capable of springing back into operation once comorbidities are addressed. Despite encouraging observational data and plausible theoretical underpinning, evidence for efficacy and safety of testosterone in this “aging” group of men is lacking; addressing comorbid illnesses remains the key priority instead. Nevertheless, in recent years, accumulation of misleading information online has triggered a global tsunami of testosterone prescriptions. Despite this, many men with organic hypogonadism remain undiagnosed or untreated; many more face a diagnostic odyssey before achieving care by the appropriate specialist. As testosterone therapy is not without risk several clinical practice guidelines have been published specialist societies to guide physicians on best practice. However, these are heterogeneous in key areas, reflecting divergent approaches to the same evidence basis. Herein, we navigate the major clinical practice guidelines on male hypogonadism and test their respective recommendations against current best evidence.

Citations

Citations to this article as recorded by

Expert Opinion on the Diagnosis and Management of Male Hypogonadism in India
Sanjay Kalra, Jubbin Jacob, A. G. Unnikrishnan, Ganapathi Bantwal, Abhay Sahoo, Rakesh Sahay, Sushil Jindal, Madhu Sudan Agrawal, Nitin Kapoor, Banshi Saboo, Mangesh Tiwaskar, Kapil Kochhar, Henrik Falhammar
International Journal of Endocrinology.2023; 2023: 1. CrossRef
Management Outcomes in Males With Hypogonadotropic Hypogonadism Treated With Gonadotropins
Bahaa O Sahib, Ibrahim H Hussein, Nassar T Alibrahim, Abbas A Mansour
Cureus.2023;[Epub] CrossRef
The Association between Inflammation, Testosterone and SHBG in men: A cross‐sectional Multi‐Ethnic Study of Atherosclerosis
Amar Osmancevic, Bledar Daka, Erin D. Michos, Penelope Trimpou, Matthew Allison
Clinical Endocrinology.2023; 99(2): 190. CrossRef
The Illusory Case for Treatment of an Invented Disease
David J. Handelsman
Frontiers in Endocrinology.2022;[Epub] CrossRef
Effect of Chronic Heart Failure Complicated with Type 2 Diabetes Mellitus on Cognitive Function in the Elderly
Yang Liu, Rui Meng, Jianzeng Dong, Xiaonan Xi
Evidence-Based Complementary and Alternative Medicine.2022; 2022: 1. CrossRef
Different Factors Are Associated With Sex Hormones and Leydig Cell Function in Israelis and Palestinians in Jerusalem
Guy Vishnevsky, Ronit Sinnreich, Hisham Nassar, Dafna Merom, Maya Ish-Shalom, Jeremy D. Kark, Hagai Levine
American Journal of Men's Health.2022; 16(4): 155798832211060. CrossRef
Association of rs9939609 polymorphism in the FTO gene with features of androgen status in men
S. V. Yankovskaya, K. I. Mosalev, I. D. Ivanov, B. B. Pinkhasov, V. G. Selyatitskaya
Сибирский научный медицинский журнал.2022; 42(2): 18. CrossRef
Clinical and pharmacological basis of the use of testosterone drugs for hormonal replacement therapy for hypogonadism in men
N. I. Volkova, A. V. Safronenko, E. V. Gantsgorn, Yu. S. Degtyareva
Obesity and metabolism.2022; 19(2): 233. CrossRef
Monitoring and Management of Bardet-Biedl Syndrome: What the Multi-Disciplinary Team Can Do
Lavinia Caba, Laura Florea, Elena Emanuela Braha, Valeriu Vasile Lupu, Eusebiu Vlad Gorduza
Journal of Multidisciplinary Healthcare.2022; Volume 15: 2153. CrossRef
Non-alcoholic fatty liver disease across endocrinopathies: Interaction with sex hormones
Sara Arefhosseini, Mehrangiz Ebrahimi-Mameghani, Farzad Najafipour, Helda Tutunchi
Frontiers in Endocrinology.2022;[Epub] CrossRef
Recommendations on the diagnosis, treatment and monitoring of testosterone deficiency in men
Bruno Lunenfeld, George Mskhalaya, Michael Zitzmann, Giovanni Corona, Stefan Arver, Svetlana Kalinchenko, Yuliya Tishova, Abraham Morgentaler
The Aging Male.2021; 24(1): 119. CrossRef

First
Prev
Page of 1
Next
Last

Search